Inotiv to Participate in the 8th Annual Lake Street Best Ideas Growth Conference
Inotiv (Nasdaq: NOTV), a leading contract research organization, announced its participation in the 8th Annual Lake Street Best Ideas Growth Conference on September 12, 2024, in New York City. Robert Leasure Jr., President and CEO, and Beth Taylor, CFO, will represent the company at the event.
The conference provides an opportunity for Inotiv's management to host one-on-one meetings with investors and attendees. This engagement allows the company to showcase its expertise in nonclinical and analytical drug discovery and development services, as well as its offerings in research models and related products.
Investors interested in arranging meetings with Inotiv's leadership should contact their Lake Street conference representative to schedule appointments.
Inotiv (Nasdaq: NOTV), una delle principali organizzazioni di ricerca a contratto, ha annunciato la sua partecipazione all'8ª Conferenza Annuale Lake Street Best Ideas Growth che si terrà il 12 settembre 2024 a New York. Robert Leasure Jr., Presidente e CEO, e Beth Taylor, CFO, rappresenteranno l'azienda all'evento.
La conferenza offre un'opportunità per il management di Inotiv di ospitare incontri individuali con investitori e partecipanti. Questo coinvolgimento consente all'azienda di mettere in mostra la sua esperienza nei servizi di scoperta e sviluppo di farmaci non clinici e analitici, così come le sue offerte in modelli di ricerca e prodotti correlati.
Gli investitori interessati a organizzare incontri con i leader di Inotiv dovrebbero contattare il loro rappresentante della conferenza Lake Street per pianificare appuntamenti.
Inotiv (Nasdaq: NOTV), una organización líder en investigación por contrato, anunció su participación en la 8ª Conferencia Anual Lake Street Best Ideas Growth que se llevará a cabo el 12 de septiembre de 2024 en la ciudad de Nueva York. Robert Leasure Jr., Presidente y CEO, y Beth Taylor, CFO, representarán a la empresa en el evento.
La conferencia ofrece una oportunidad para que el equipo directivo de Inotiv realice reuniones uno a uno con inversores y asistentes. Este compromiso permite a la empresa mostrar su experiencia en servicios de descubrimiento y desarrollo de medicamentos no clínicos y analíticos, así como sus productos en modelos de investigación y productos relacionados.
Los inversores interesados en organizar reuniones con el liderazgo de Inotiv deben contactar a su representante de la conferencia Lake Street para programar citas.
Inotiv (나스닥: NOTV), 선도적인 계약 연구 기관,이 2024년 9월 12일 뉴욕에서 열리는 제8회 레이크 스트리트 최고의 아이디어 성장 컨퍼런스에 참가한다고 발표했습니다. 로버트 리저 주니어 CEO 및 베스 테일러 CFO가 행사에 회사 대표로 참석합니다.
이번 컨퍼런스는 Inotiv의 경영진이 투자자 및 참석자와의 일대일 미팅을 진행할 수 있는 기회를 제공합니다. 이러한 참여는 회사가 비임상 및 분석 약물 발견 및 개발 서비스에 대한 전문성과 연구 모델 및 관련 제품에 대한 제안을 선보일 수 있도록 합니다.
Inotiv의 리더십과 회의 예약을 원하시는 투자자는 레이크 스트리트 컨퍼런스 담당자에게 연락하여 약속을 잡아야 합니다.
Inotiv (Nasdaq: NOTV), une organisation de recherche contractuelle de premier plan, a annoncé sa participation à la 8ème Conférence Annuelle Lake Street Best Ideas Growth qui se tiendra le 12 septembre 2024 à New York. Robert Leasure Jr., Président et CEO, et Beth Taylor, CFO, représenteront l'entreprise lors de cet événement.
La conférence offre une occasion pour le management d'Inotiv d'organiser des réunions individuelles avec des investisseurs et participants. Cet engagement permet à l'entreprise de mettre en avant son expertise dans les services de découverte et de développement de médicaments non cliniques et analytiques, ainsi que ses offres en modèles de recherche et produits associés.
Les investisseurs intéressés à organiser des réunions avec les dirigeants d'Inotiv devraient contacter leur représentant de la conférence Lake Street pour convenir de rendez-vous.
Inotiv (Nasdaq: NOTV), eine führende Vertragsforschungsorganisation, kündigte ihre Teilnahme an der 8. jährlichen Lake Street Best Ideas Growth Konferenz am 12. September 2024 in New York City an. Robert Leasure Jr., Präsident und CEO, und Beth Taylor, CFO, werden das Unternehmen bei der Veranstaltung vertreten.
Die Konferenz bietet dem Management von Inotiv die Möglichkeit, eins-zu-eins-Meetings mit Investoren und Teilnehmern abzuhalten. Dieses Engagement ermöglicht es dem Unternehmen, seine Expertise in nichtklinischen und analytischen Medikamentenentdeckungs- und Entwicklungsdiensten sowie seine Angebote in Forschungsmodellen und verwandten Produkten zu präsentieren.
Investoren, die an der Organisation von Treffen mit der Geschäftsführung von Inotiv interessiert sind, sollten sich an ihren Lake Street-Konferenzvertreter wenden, um Termine zu vereinbaren.
- None.
- None.
WEST LAFAYETTE, Ind., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, announced today that Robert Leasure Jr., Inotiv’s President and Chief Executive Officer, and Beth Taylor, Chief Financial Officer, will participate in the 8th Annual Lake Street Best Ideas Growth Conference on Thursday, September 12, 2024, in New York City.
Management is scheduled to host one-on-one meetings with investors and attendees during the conference. Investors interested in arranging one-on-one meetings should contact their Lake Street conference representative.
About Inotiv
Inotiv, Inc. is a leading contract research organization dedicated to providing nonclinical and analytical drug discovery and development services and research models and related products and services. The Company’s products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development, all while increasing efficiency, improving data, and reducing the cost of taking new drugs to market. Inotiv is committed to supporting discovery and development objectives as well as helping researchers realize the full potential of their critical R&D projects, all while working together to build a healthier and safer world. Further information about Inotiv can be found here: https://www.inotiv.com/.
This release may contain forward-looking statements that are subject to risks and uncertainties including, but not limited to, risks and uncertainties related to the impact of recent events related to non-human primate matters on the Company’s business, operations, results, financial condition, cash flows, and assets, the Company’s ability to service its outstanding indebtedness and comply with covenants under its credit agreement, compliance with the Resolution and Plea Agreements with the DOJ and the expected impacts on the Company related to the compliance plan, compliance monitor, and the expected financial commitments, changes in the market and demand for the Company’s products and services, the development, marketing and sales of products and services, changes in technology, industry and regulatory standards, the timing of acquisitions and the successful closing, integration and business and financial impact thereof, governmental regulations, inspections and investigations, claims and litigation against or involving the Company, its business and/or its industry, the impact of site closures and consolidations, expansion and related efforts, and various other market and operating risks, including those detailed in the Company's filings with the U.S. Securities and Exchange Commission.
| Company Contact Inotiv, Inc. Beth A. Taylor, Chief Financial Officer (765) 497-8381 beth.taylor@inotiv.com | Investor Relations LifeSci Advisors Bob Yedid (516) 428-8577 bob@lifescieadvisors.com |
FAQ
When and where is Inotiv (NOTV) participating in the Lake Street Best Ideas Growth Conference?
Who will represent Inotiv (NOTV) at the Lake Street conference?
What type of meetings will Inotiv (NOTV) management host during the conference?
How can investors arrange meetings with Inotiv (NOTV) management at the conference?
What services does Inotiv (NOTV) specialize in as a contract research organization?
